Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bernstein SocGen has maintained an Outperform rating on Netflix with a $115 price target, implying roughly 38% upside from the stock's current level. The firm highlights attractive entry levels after the company’s fourth-quarter results, while flagging three unresolved overhangs that will affect returns. The proposed $83 billion bid for Warner Bros…
Lucid Capital Markets downgraded Quince Therapeutics Inc. (QNCX) from Buy to Sell and removed its price target after the company announced that its pivotal Phase 3 NEAT trial failed to meet both primary and key secondary endpoints. The trial miss, the decision to discontinue the program that represented Quince’s sole development asset, and the comp…
India’s economy is expected to expand above 7% this fiscal year, yet the chief economic adviser warned that global macroeconomic uncertainty and sustained financial market corrections could push growth toward the lower bound of official projections. The finance ministry’s economic survey projects 6.8% to 7.2% growth for the next fiscal year and rai…
Citi upgraded Spotify to a Buy rating and maintained a $650 price target, arguing the streaming company’s shares are undervalued relative to 2027 free cash flow metrics. Analyst Jason Bazinet says Citi expects Spotify to outpace Wall Street revenue and adjusted EBITDA forecasts, driven by slightly stronger Premium average revenue per user and margi…
AstraZeneca has obtained global rights (excluding certain Chinese territories) to several of CSPC Pharmaceutical Group's experimental obesity therapies under a deal that carries $1.2 billion in upfront consideration and up to $17.3 billion in milestone payments. The agreement expands an existing collaboration between the two firms, covers developme…
Gold, silver and copper reversed course on Friday as investors moved to lock in gains after a string of record highs. Market participants cited waning expectations for aggressive U.S. interest rate cuts and a firmer dollar following the announcement of Kevin Warsh as the preferred candidate to lead the U.S. Federal Reserve. Thin liquidity and specu…
Rosenblatt lowered its price target for Dynatrace Inc. (DT) to $60 from $67 while keeping a Buy rating ahead of the company’s Q3/FY26 earnings release. The stock trades near its 52-week low, and the analyst cited comparable multiple compression and enterprise spending pressure as the primary reasons for the reduction. Rosenblatt anticipates essenti…
Needham raised its price target on Deckers Outdoor to $138 from $115 and kept a Buy rating after the footwear maker reported fiscal third-quarter 2026 results that beat expectations. Deckers recorded 7% revenue growth and $3.33 in EPS for the quarter, lifted its full-year sales and EPS guidance, and drew upgraded forecasts and target changes from o…
Needham raised its price target for Stryker (NYSE: SYK) to $454 from $448 and kept a Buy rating after the company posted fourth-quarter results that beat consensus. The quarter showed improving organic sales growth and margin expansion at the operating level, while management provided 2026 guidance that aligns with street expectations but flags a $…
Electro Optic Systems (EOS) is preparing to relocate its headquarters and stock-market listing from Australia to Europe within a year, its CEO said, citing accelerating demand across the continent for laser-based drone-defence systems and worries among governments about where intellectual property is held. The company has already secured a 71 milli…
USCB Financial Holdings President and CEO Luis De La Aguilera sold 10,000 Class A shares on January 29, 2026, for $180,200 and exercised options to acquire 10,000 shares the same day. The transactions leave him with 245,893 directly owned shares and several option tranches. The firm reported mixed fourth-quarter 2025 results that missed analyst exp…
ProMIS Neurosciences announced a private placement agreement that could generate up to $175 million, sending its stock up 24%. The initial gross proceeds are expected to be about $75 million, with another $100 million possible if warrants issued in the deal are fully exercised. Management and institutional investors are participating; closing is ta…
Rosenblatt lowered its price objective on Calix to $70 from $85 while keeping a Buy rating following the company’s fourth-quarter 2025 results and mixed first-quarter guidance. Calix reported record quarterly and annual revenue, but management warned of rising memory costs that are expected to affect shipments after the first quarter and will likel…
The Swiss National Bank (SNB) has denied engaging in any manipulation of the Swiss franc after the U.S. Treasury kept Switzerland on a watch list for potential currency management. The Treasury said it is expanding monitoring of foreign exchange practices, including interventions that counter both depreciation and appreciation versus the U.S. dolla…
Palladyne AI pairs hardware robotics with autonomy software and a recent cybersecurity partnership. The market is pricing the company like a growth software story while revenue proof is still emerging. We think a mid-term long trade captures re-rating potential from new contract wins and recurring software sales, while respect for headline valuatio…
Israel said it will reopen the Rafah border crossing with Egypt on Sunday for people traveling between Gaza and Egypt, marking the first reopening of the crossing since it was seized in May 2024. The Israeli civil coordination body COGAT said returns will be limited to Gaza residents who left during the war and will require prior Israeli security c…
Microsoft has been weak on AI anxiety headlines, but beneath the headlines the company still posts strong cloud growth, a massive $625B commercial backlog, $77.4B in free cash flow and a fortress balance sheet. The market is trading off near-term execution fears; that creates a tactical buy opportunity for a swing trade with defined risk.
With fourth-quarter earnings on the horizon, BofA Securities has identified a set of companies it believes are well placed to manage AI-driven disruption, tighter cost discipline and uneven enterprise IT spending. The bank highlights a large-cap software leader supported by resilient cloud demand and several niche winners across travel software, fi…
Wedbush reaffirmed an Outperform rating and a $350 price target for Apple following the company’s fiscal first-quarter 2026 results. The quarter featured notable iPhone strength, particularly in China, and guidance that outpaces Street expectations, while analysts highlight an uncounted AI premium and elevated valuation multiples.
UBS maintained a Neutral rating and a $19.00 price target on Energizer Holdings Inc. (ENR) ahead of the company's fiscal first-quarter results on February 5. The firm projects Q1 EPS of $0.25, noting pressures from difficult year-ago comparisons tied to storm-driven demand and early display shipment headwinds. Despite a low P/E and a sizable divide…
Rosenblatt Securities raised its 12-month price target for Apple to $267 from $250 while maintaining a Neutral rating. The adjustment follows a fiscal first-quarter 2026 beat driven by stronger-than-expected iPhone demand and improved gross margins, even as Rosenblatt and other firms weigh valuation and potential margin pressures.
Mizuho increased its 12-month price target for Eastman Chemical (EMN) from $68.00 to $75.00 while retaining an Outperform rating. The lift in the target reflects higher market and peer valuation multiples even as the company reported softer fourth-quarter 2025 operating results and issued conservative near-term EPS guidance amid macro uncertainty.
D. Boral Capital lowered its rating on Quince Therapeutics Inc. (QNCX) from Buy to Hold after the company reported negative Phase 3 results for its eDSP program in Ataxia-Telangiectasia. The stock plunged sharply, management has stopped clinical development of eDSP, and the company is pivoting toward conserving cash and evaluating strategic options…
Bernstein SocGen Group raised its price objective for SanDisk to $1,000 from $580 and kept an Outperform rating after the company reported second-quarter revenue and non-GAAP EPS that beat consensus. Management's third-quarter revenue and margin guidance drove the analyst's sharper outlook and prompted similar target increases from several peers, w…
Wedbush has reaffirmed an Outperform rating and a $340.00 price target for Amazon.com (AMZN) ahead of the company’s fourth-quarter earnings report scheduled for February 5. The firm raised its operating income estimates, highlighted accelerating demand and capacity additions at Amazon Web Services (AWS), and said continued strong AWS performance co…
